Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation: Erratum.
出版信息
J Hypertens. 2025 Jun 1;43(6):1089. doi: 10.1097/HJH.0000000000004012. Epub 2025 Apr 30.
Abstract
摘要
相似文献
1
Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation: Erratum.
J Hypertens. 2025 Jun 1;43(6):1089. doi: 10.1097/HJH.0000000000004012. Epub 2025 Apr 30.
2
Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation.时间序列蛋白质组谱分析揭示柠檬酸合酶在血管紧张素Ⅱ诱导的心房颤动中的保护作用。
J Hypertens. 2022 Apr 1;40(4):765-775. doi: 10.1097/HJH.0000000000003075.
3
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.阻断肾素-血管紧张素-醛固酮系统（RAAS）用于非瓣膜性心房颤动的一级预防：随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2013 Apr 30;165(1):17-24. doi: 10.1016/j.ijcard.2012.02.009. Epub 2012 Mar 14.
4
4-Hydroxychalcone alleviated Angiotensin II-induced atrial fibrillation via immunoproteasome-IKK-NF-κB signaling pathway modulation.4-羟基查尔酮通过调节免疫蛋白酶体-IKK-NF-κB信号通路减轻血管紧张素II诱导的心房颤动。
J Mol Med (Berl). 2025 Aug 19. doi: 10.1007/s00109-025-02587-0.
5
Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.沙库巴曲缬沙坦与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂在预防导管消融术后房颤复发中的疗效：一项系统评价和荟萃分析。
Herz. 2025 Apr;50(2):135-141. doi: 10.1007/s00059-024-05275-w. Epub 2024 Sep 23.
6
Inhibition of TREM-1 ameliorates angiotensin II-induced atrial fibrillation by attenuating macrophage infiltration and inflammation through the PI3K/AKT/FoxO3a signaling pathway.TREM-1 抑制通过 PI3K/AKT/FoxO3a 信号通路减轻巨噬细胞浸润和炎症从而改善血管紧张素 II 诱导的心房颤动。
Cell Signal. 2024 Dec;124:111458. doi: 10.1016/j.cellsig.2024.111458. Epub 2024 Oct 9.
7
Effect of RAAS blockers on adverse clinical outcomes in high CVD risk subjects with atrial fibrillation: A meta-analysis and systematic review of randomized controlled trials.肾素-血管紧张素-醛固酮系统阻滞剂对高心血管疾病风险的房颤患者不良临床结局的影响：一项随机对照试验的荟萃分析和系统评价
Medicine (Baltimore). 2016 Jun;95(26):e4059. doi: 10.1097/MD.0000000000004059.
8
A Systematic Review and Meta-analysis of Renin-angiotensin System Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence After Atrial Fibrillation Ablation.一项关于肾素-血管紧张素系统抑制剂和血管紧张素受体脑啡肽酶抑制剂在预防心房颤动消融后复发的系统评价和荟萃分析。
J Cardiovasc Pharmacol. 2024 Mar 1;83(3):220-227. doi: 10.1097/FJC.0000000000001517.
9
Computational modelling of cardiac fibroblast signalling reveals a key role for Ca in driving atrial fibrillation-associated fibrosis.心脏成纤维细胞信号传导的计算模型揭示了钙离子在驱动心房颤动相关纤维化中的关键作用。
J Physiol. 2025 Jun 19. doi: 10.1113/JP289040.
10
The Impact of Beta-Blockers and Renin-Angiotensin-Aldosterone System Inhibitors on the Prognosis of Atrial Fibrillation Patients with Chronic Obstructive Pulmonary Disease: A Nation-Wide Registry Study.β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂对慢性阻塞性肺疾病合并心房颤动患者预后的影响：一项全国性登记研究
Int J Chron Obstruct Pulmon Dis. 2025 Mar 13;20:699-708. doi: 10.2147/COPD.S511117. eCollection 2025.
本文引用的文献
1
Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation.时间序列蛋白质组谱分析揭示柠檬酸合酶在血管紧张素Ⅱ诱导的心房颤动中的保护作用。
J Hypertens. 2022 Apr 1;40(4):765-775. doi: 10.1097/HJH.0000000000003075.
Zotero 插件